Two hedge-fund firms including David Tepper’s Appaloosa LP are calling for changes at Allergan PLC, urging the pharmaceutical company to split its chairman and chief executive roles and add more focus to its wide-ranging strategic review. Appaloosa and Senator Investment Group LP had previously telegraphed those desires to Allergan, but are turning the screws on the company by making their demands public. In a letter Tuesday to Allergan’s board of directors, released publicly, the activists call for a split of offices both...

Source: Wall Street Journal June 05, 2018 17:54 UTC